Bruker Corporation

Bruker Corporation

Bruker Corporation (BRKR) is a US-headquartered maker of scientific instruments used in life sciences, materials research and diagnostics. Its product mix includes mass spectrometers, nuclear magnetic resonance (NMR) systems, X-ray diffraction and imaging platforms, and related consumables and service contracts. With a market capitalisation near $5.9 billion, Bruker sits in the smallโ€‘toโ€‘mid cap segment where growth can be driven by R&D spending, academic and pharmaceutical investment, and demand for advanced analytical tools. Strengths include a diversified technology base, recurring service and consumable revenues, and a global sales footprint. Key risks are capitalโ€‘equipment cyclicality, competition from larger instrument groups, exposure to currency and supplyโ€‘chain pressures, and the need for sustained R&D investment. Investors should treat Bruker as a growthโ€‘oriented industrial/scientific instruments play and note that returns are not guaranteed; values can fall as well as rise. This is general educational information, not personalised investment advice.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts suggest buying Bruker Corporation's stock with a target price of $49.5, indicating growth potential.

Above Average

Financial Health

Bruker Corporation is performing well with solid revenue, cash flow, and profit margins.

Below Average

Dividend

Bruker Corporation has a low dividend yield of 0.42%, which may not appeal to income-focused investors. If you invested $1000 you would be paid $4.20 a year in dividends (based on the last 12 months).

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring BRKR

Post-Archegos Compliance Tech

Post-Archegos Compliance Tech

This carefully selected group of stocks represents companies providing the essential regulatory and compliance technologies banks now desperately need. After a massive $120 million settlement, financial institutions are under intense pressure to improve their risk management systems, creating valuable opportunities for tech providers in this space.

Published: July 15, 2025

Explore Basket

Why Youโ€™ll Want to Watch This Stock

๐Ÿ“ˆ

Recurring Revenue Engine

Service contracts and consumables provide a steady income stream that can temper equipmentโ€‘sale cyclicality, though performance can vary with customer investment cycles.

๐ŸŒ

Global R&D Exposure

Bruker benefits from demand across academia, pharma and industry worldwide, but is exposed to FX, regional funding shifts and supplyโ€‘chain risks.

โšก

Innovation and Competition

Sustained R&D and selective acquisitions drive product differentiation, while competition from larger instrument groups and the need for capital investment remain ongoing challenges.

Why invest with Nemo?

Nemo Logo Fade
๐Ÿ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

๐Ÿ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

๐Ÿ’ฐ

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

A

Agilent Technologies Inc.

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

ALGN

Align Technology Inc.

Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.

Frequently asked questions